Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration

Diabetes

Volumn 51, Issue 8, 2002, Pages 2619-2628

  Pop Busui, Rodica ^a   Marinescu, Victor ^a   Van Huysen, Carol ^a   Li, Fei ^a   Sullivan, Kelli ^a   Greene, Douglas A ^a   Larkin, Dennis ^a   Stevens, Martin J ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CYCLOOXYGENASE 2 INHIBITOR; FLURBIPROFEN; FRUCTOSE; GLUCOSE; INOSITOL; LEVACECARNINE; MELOXICAM; POLYCLONAL ANTIBODY; PROSTAGLANDIN SYNTHASE INHIBITOR; SORBITOL; TAURINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG EFFECT; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LASER DOPPLER FLOWMETRY; NERVE CONDUCTION; NERVE FUNCTION; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT; STREPTOZOCIN DIABETES;

EID: 0036323283     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.8.2619     Document Type: Article

References (80)

1. The effect of intensive diabetes therapy on the development and progression of neuropathy
2. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats
3. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy
4. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats
5. Effects of alphalipoic acid on neurovascular function in diabetic rats: Interaction with essential fatty acids
6. The pathogenesis of diabetic neuropathy
7. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway
8. Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress
9. Role of oxidative stress in development of complications of diabetes
10. Hydroxyl radical production and autoxidative glycosylation: Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing
11. Hyperglycemia in the pathogenesis of diabetic complications
12. Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats
13. Alterations in tissue antioxidant systems in the spontaneously diabetic (BB Wistar) rat
14. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense
15. Inhibition of phosphatidylinositol synthase by glucose in human retinal pigment epithelial cells
16. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications
17. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat
18. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy
19. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy
20. Effect of alpha-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve
21. Free radicals mediate endothelial cell dysfunction caused by elevated glucose
22. The relationship of vascular changes to metabolic factors in diabetes melhtus and their role in the development of peripheral nerve complications
23. Interactions between essential fatty acid, prostenoid, polyol pathway and nitric oxide metabolism in the neurovascular deficit of diabetic rats
24. The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats
25. The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus
26. Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats
27. Altered synthesis of prostaglandins in platelet and aorta from spontaneously diabetic Wistar rats
28. Possible role of lipid peroxidation in the induction of NF-kappaB and AP-1 in RFL-6 cells by crocidolite asbestos: Evidence following protection by vitamin E
29. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2
30. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells
31. Role of prostaglandin H2 as an endothelium-derived contracting factor in diabetic state
32. Decreased vascular prostacyclin in experimental diabetes
33. Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat
34. The interaction of long-chain acyl CoA with membranes
35. The roles of glucose-induced metabolic hypoxia and imbalances in carnitine metabolism in mediating diabetes-induced vascular dysfunction
36. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
37. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs
38. The primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the BB/W-rat
39. Essential fatty acid diet supplementation: Effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats
40. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: Dose-response considerations and independence from a myo-inositol mechanism
41. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase 1
42. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4′-isomer
43. A rapid method for taurine quantitation using high performance liquid chromatography
44. Nerve ischaemia in diabetic rats: Time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models
45. Depletion of taurine in experimental diabetic neuropathy: Implications for nerve metabolic, vascular, and functional deficits
46. Effects of dietary supplementation with arachidonic acid rich oils on nerve conduction and blood flow in streptozotocin-diabetic rats
47. Action of sorbinil in diabetic peripheral nerve: Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity
48. The influence of indomethacin and guanethidine on experimental streptozotocin diabetic neuropathy
49. The influence of sulindac on experimental streptozotocin-induced diabetic neuropathy
50. Piroxicam may reduce the rate of progression of experimental diabetic neuropathy
51. Drug-induced peripheral neuropathies
52. Peripheral neuropathy and indomethacin
53. Neurologic adverse effects during concomitant treatment with ciprofloxacin, NSAIDs, and chloroquine: Possible drug interaction
54. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays
55. Pharmacology and efficacy of cyclooxygenase (COX) inhibitors
56. Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs)
57. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
58. Function and regulation of prostaglandin synthase-2
59. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide
60. Cyclooxygenase-2 is induced in microglia during chronic cerebral ischemia in humans
61. Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-kappaB
62. Cyclooxygenase in biology and disease
63. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy
64. Effects of DL-α-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy
65. +-ATPase activity, and vascular supply in STZ-D rats
66. Analysis of H2 clearance curves used to measure blood flow in rat sciatic nerve
67. Evaluation of α1-adrenoceptor antagonist and antioxidant therapy on diabetes-induced changes in retinal NAD(P)-redox status: Evidence against "pseudohypoxia"?
68. Amphipatic metabolites and membrane dysfunction in ischemia myocardium
69. Stereoselective and substrate-dependent inhibition of hepatic mitochondria beta-oxidation and oxidative phosphorylation by the non-steroidal anti-inflammatory drugs ibuprofen, flurbiprofen, and ketorolac
70. The effect of the enantiomers of ibuprofen and flurbiprofen on the beta-oxidation of palmitate in the rat
71. Effect of L-carnitine and acetyl-L-carnitine on the human erythrocyte membrane stability and deformability
72. Downregulation of the human taurine transporter by glucose in cultured retinal pigment epithelial cells
73. Renal Na-myo-inositol cotransporter mRNA expression in Xenopus oocytes: Regulation by hypertonicity
74. Inhibition by taurine of the phosphorylation of specific synaptosomal proteins in the rat cortex: Effects of taurine on the stimulation of calcium uptake in mitochondria and inhibition of phosphoinositide turnover
75. +-ATPase activity of rats with streptozocin-induced diabetes is mediated via cAMP: Possible role of cAMP in diabetic neuropathy
76. In vivo phosphorylation of the Na,K-ATPase alpha subunit in sciatic nerves of control and diabetic rats: Effects of protein kinase modulators
77. Effects of acute experimental diabetes on composite energy metabolism in peripheral nerve axons and Schwann cells
78. Non-enzymatic conversion of all-cis 8,11,14-eicosatrienoic acid into prostaglandin E1
79. Peroxidative stress and cerebral aging
80. Systemic acetyl-L-carnitine elevates nigral levels of glutathione and GABA